NeuroscienceBiomedicine & PharmacotherapyPeer-reviewed
Potent and reversible open-channel blocker of NMDA receptor derived from dizocilpine with enhanced membrane-to-channel inhibition
Anna Misiachna, Jan Konecny, Marharyta Kolcheva…·Martin Hořák
This paper develops a novel NMDA receptor open-channel blocker, K2060, showing improved efficacy and reversibility compared to existing drugs like memantine and dizocilpine.
8 citations